Patents by Inventor Morgane Rolland

Morgane Rolland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inducing an immune response against HIV-1 using recombinant envelopes with improved coverage
    Patent number: 10906941
    Abstract: The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: February 2, 2021
    Inventors: Jerome Kim, Morgane Rolland, Bette T. Korber, Barton F. Haynes
  • POLYVALENT HIV-1 IMMUNOGEN
    Publication number: 20160115205
    Abstract: The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
    Type: Application
    Filed: April 15, 2014
    Publication date: April 28, 2016
    Inventors: Jerome Kim, Morgane Rolland, Bette T. Korber, Barton F. Haynes
  • Conserved-Element Vaccines and Methods for Designing Conserved-Element Vaccines
    Publication number: 20110269937
    Abstract: Embodiments of the present invention include conserved-element vaccines and methods for designing and producing conserved-element vaccines. A conserved-element vaccine (“CEVac”) is a recombinant and/or synthetic vaccine that incorporates only highly conserved epitopes from an observed set of pathogen variants. The conserved epitopes are identified computationally by aligning biopolymer sequences, such as concatenated polypeptide sequences that together represent a pathogen proteome, corresponding to an observed set of pathogen variants, and computationally selecting conserved subsequences according to a number of subsequence-selection criteria.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 3, 2011
    Applicants: higher education
    Inventors: James Mullins, David Nickle, Morgane Rolland
  • Conserved-element vaccines and methods for designing conserved-element vaccines
    Publication number: 20090092628
    Abstract: Embodiments of the present invention include conserved-element vaccines and methods for designing and producing conserved-element vaccines. A conserved-element vaccine (“CEVac”) is a recombinant and/or synthetic vaccine that incorporates only highly conserved epitopes from an observed set of pathogen variants. The conserved epitopes are identified computationally by aligning biopolymer sequences, such as concatenated polypeptide sequences that together represent a pathogen proteome, corresponding to an observed set of pathogen variants, and computationally selecting conserved subsequences according to a number of subsequence-selection criteria.
    Type: Application
    Filed: March 2, 2007
    Publication date: April 9, 2009
    Inventors: James Mullins, David Nickle, Morgane Rolland